Phage Directory Phage Directory

Stephanie Lynch, PhD

The Westmead Institute for Medical Research; Phage Australia; Iredell Lab

Stephanie is a postdoctoral researcher for the Iredell Group at Westmead Institute for Medical Research, NSW. Her project focuses on phage therapy for compassionate human cases (as part of Phage Australia), with a particular interest in Staphylococcal phages. In 2021, Stephanie completed her thesis titled ‘Exploring phage therapy for Staphylococcus pseudintermedius infections in canines'. Steph is always willing to chat about phage research and would like to connect with phage biotech companies.

Tags

Loading issues…

  1. Phage down under: stability of a travelling phageThe Phage Australia network recently shipped a purified phage to collaborators across the country, and had everyone titre it and report back. Stephanie Lynch, who spearheaded this effort, tells us what was done and what the team learned.179Stephanie Lynch
  2. C&T Round Up for Dec & Jan!This week, we highlight the features we published in Dec & Jan! Learn about combining phages with antibiotics, scaling up phage production, the new Web3 x science movement, and catch Phage Directory's 2021 reflection and 2022 outlook!161Stephanie Lynch
  3. Flipping the turtle back on its flippers: Phage therapy to combat a shell infection in a sea turtleRemember when Shelley the sea turtle got phage therapy, thanks to the phage community? This week, Stephanie Lynch distills main learnings from the paper and shares her interview with Shelley's vet, plus a webinar/Q&A that dives deeper!154Stephanie Lynch
  4. C&T Round Up for October 2021This week, we highlight the feature articles we published in October! Learn about the phages being collected around the world, a doctor-patient experience with phage therapy, successful use of phage to treat bacterial prostatitis, and…151Stephanie Lynch
  5. C&T Round Up for September 2021This week, we highlight the four feature articles we published in September! Learn about a new plaque counting app by Michael Shamash, a new plaque sizing tool by Ellina Trofimova, how Australian pediatrician Ameneh Khatami is treating kids…146Stephanie Lynch
  6. Phage therapy for difficult-to-treat infections in children, with Dr. Ameneh KhatamiIn our July PHAVES series, Dr. Ameneh Khatami, a paediatric infectious disease physician and senior lecturer at the University of Sydney, spoke about phage therapy for difficult to treat infections in children. Here’s the recording, along…143Sayde Perry, Stephanie Lynch
  7. C&T Round Up for August 2021This week, we’re highlighting the three features we published in August! We've got a reflection on African phage scientists' challenges and progress by Raphael Hans Lwesya, a reflection (plus stats!) on Evergreen 2021 (including how to…141Stephanie Lynch
  8. C&T Round Up for July 2021This week, we’re highlighting the four features we published in July! We've got a sneak-peek into the upcoming Evergreen Phage Meeting, a blog post on Phage Directory's new phage research feedback exchange initiative, 'Instill', an…137Stephanie Lynch
  9. C&T Round Up for June 2021This week, we’re highlighting the three feature articles we published in June: a guest blog post by David Sáez and Lorenzo Corsini on breeding better phages, a recap of a clinical phage therapy case presented in PHAVES by Dr. Laura Damioli…132Stephanie Lynch
  10. Viral Host Range Database: an online tool for recording, analyzing and disseminating virus-host interactionsLast month in our PHAVES series, Quentin Lamy-Besnier, a PhD student in the Debarbieux lab, introduced the Viral Host Range Database their group has developed. This online resource lets you find, document, analyze and distribute information…131Stephanie Lynch
  11. Freedom from antibiotic purgatory? Salvage phage therapy for cure of spinal hardware infectionIn our PHAVES seminar series last month, Dr. Laura Damioli and Dr. Greg Canfield (University of Colorado Anschutz) shared their experience treating their first patient with phage therapy for a spinal hardware infection. Here's the…130Stephanie Lynch
  12. Clinical phage therapy, phages for plant pathogens & phage bioinformatics: A triple webinar recap issue!This week, we've got highlights and recordings for 3 webinars we hosted this month: An interview with Dr. Randy Fish on clinical phage therapy for diabetic foot wounds, a talk by Dr. Clara Torres-Barceló on plant pathogen phage research,…123Stephanie Lynch
  13. C&T Round Up for March 2021This week, we're highlighting the three feature articles we published in March: a quick dive into phage and diabetic foot ulcers, a recap of the Phage Futures conference last month, and a recap of Jon Iredell's PHAVES seminar this month on…119Stephanie Lynch
  14. Phage therapy: The Australian experienceEarlier this month we hosted PHAVES #13, a talk by Prof. Jonathan Iredell, who shared his group's experience with phage therapy at the Westmead Institute for Medical Research in Sydney, Australia. Here's the recording, along with a recap by…118Stephanie Lynch
  15. C&T Round Up for January 2021This week, we're highlighting the four feature articles we published in January: Phage Directory's 2021 outlook, a guest blog post, an interview, and a first look at our State of Phage survey results! Enjoy!111Stephanie Lynch
  16. Engineering phage ΦX174's genome: a recap of November's PHAVES talkThis month, we hosted episode 10 of PHAVES, a talk on phage engineering by Dr. Paul Jaschke, Lecturer at Macquarie University! Here's the recording, along with a recap written by Stephanie Lynch, PhD candidate at La Trobe University (and…103Stephanie Lynch
  17. Not all viruses: Bacterial viruses against canine pyodermaPhages for dogs too? This week, Stephanie Lynch, a PhD candidate at La Trobe University in Melbourne, Australia, tells us about her research into phages and endolysins to treat multidrug-resistant Staphylococcus pseudintermedius infections…72Stephanie Lynch

Showing 1–17 of 17 issues

Source-reported research

Research context

AI-assisted source report. It may be incomplete or mistaken and may not reflect current work. As of . Reviewed .

  • 2026-08-01: coauthored “Characterization and host range associating factors of Staphylococcus aureus bacteriophage PBSA08; Using Australian MRSA reference set”. [2] [3] [4]
Sources and review
  1. phage.directory Observed . Native directory ID and submitted public anchors in the frozen roster
  2. doi.org Observed . Existing accepted exact-work author slot
  3. doi.org Observed . Existing accepted own DOI
  4. doi.org Observed . Existing accepted work title

Reviewed by ai:codex-identities-ce68394c9be2. Consolidated final review. Concise dated publication-history context cites the exact supported author/work evidence; no current-project, current-employment, individual-contribution or unobserved result claims. Older work is dated and does not count as a recent-paper selection.

Source-selected papers

AI-assisted source report. It may be incomplete or mistaken and may not reflect current work. Reviewed .

Sources and review
  1. phage.directory Observed . Native directory ID and submitted public anchors in the frozen roster
  2. doi.org Observed . Existing accepted exact-work author slot
  3. doi.org Observed . Existing accepted own DOI
  4. doi.org Observed . Existing accepted work title
  5. doi.org Observed . Canonical exact-DOI native paper ID

Reviewed by ai:codex-identities-ce68394c9be2. Consolidated final review of exact own DOI, actual author slot/identifier or independently accepted work affiliation, phage relevance and source date. Native IDs resolve the same DOI; candidate namesakes and alternate editions remain explicit holds. No global identity or employment/contribution inference.